Sleep drug shows promise for treating depression in seniors
NCT ID NCT06867549
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a low or moderate dose of propofol, a sleep-inducing drug, combined with brief behavioral therapy for insomnia, can improve sleep and depression symptoms in adults aged 60 and older with treatment-resistant depression. Seventy participants will receive two propofol infusions and several therapy sessions. The goal is to see if boosting deep sleep can help ease depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine/Barnes-Jewish Hospital
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression โ a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?
- What did COVID-19 mean for family caregivers in zambia? a study seeks answers